Calculated age, sex and area SIR for observed cancers at all sites, at all sites excluding NMSC and by site ordered by decreasing numbers of observed cancer cases
| No. of cancers | |||||
|---|---|---|---|---|---|
| Cancer site | PY | Observed | Expected | SIR (95% CI) | p Value |
| All sites | 2553 | 50 | 31.71 | 1.58 (1.17 to 2.08) | 0.003 |
| All non-NMSC sites | 2580 | 35 | 27.00 | 1.30 (0.90 to 1.80) | 0.16 |
| By cancer site | |||||
| NMSC | 2618 | 15 | 5.39 | 2.78 (1.56 to 4.59) | 0.001 |
| Prostate | 2623 | 8 | 4.40 | 1.82 (0.78 to 3.58) | 0.16 |
| Lung | 2648 | 5 | 3.89 | 1.29 (0.42 to 3.00) | 0.70 |
| Bladder | 2645 | 4 | 1.66 | 2.41 (0.66 to 6.17) | 0.17 |
| Breast | 2645 | 3 | 3.06 | 0.98 (0.20 to 2.87) | 1.0 |
| Colorectal | 2640 | 3 | 3.96 | 0.76 (0.16 to 2.21) | 0.88 |
| Larynx | 2647 | 2 | 0.30 | 6.67 (0.81 to 24.08) | 0.07 |
| Endometrium | 2643 | 2 | 0.61 | 3.26 (0.40 to 11.84) | 0.25 |
| Leukaemia | 2649 | 2 | 0.62 | 3.25 (0.39 to 11.65) | 0.26 |
| Thyroid | 2645 | 1 | 0.18 | 5.56 (0.14 to 30.95) | 0.33 |
| Myeloma | 2649 | 1 | 0.41 | 2.44 (0.06 to 13.59) | 0.67 |
| Liver | 2650 | 1 | 0.56 | 1.79 (0.05 to 9.95) | 0.86 |
| Pancreas | 2650 | 1 | 0.75 | 1.33 (0.03 to 7.43) | 1.0 |
| Non-Hodgkin's lymphoma | 2646 | 1 | 0.90 | 1.11 (0.03 to 6.19) | 1.0 |
| Stomach | 2643 | 1 | 1.11 | 0.90 (0.02 to 5.02) | 1.0 |
NMSC, non-melanoma skin cancer; PY, person-years; SIR, standardised incidence ratio.